SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-000338
Filing Date
2024-01-03
Accepted
2024-01-03 17:29:45
Documents
14
Period of Report
2023-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54171
2 ex2-1.htm EX-2.1 25171
3 ex10-1.htm EX-10.1 230027
  Complete submission text file 0001493152-24-000338.txt   518268

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20231227.xsd EX-101.SCH 3033
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20231227_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20231227_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3207
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 24508308
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)